Jeffrey T. L. Smith, Managing Director at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 10,088 shares at $13.84 ($140K) on 2018-12-03, disclosed to the SEC on 2018-12-04.
Open-market sale of $140k ALDR by Managing Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.84 | 5,044 | $70K | 50.0% |
| 2 | $13.84 | 5,044 | $70K | 50.0% |
| Total | $13.84 avg | 10,088 | $140K | 100% |
| Filing → |
| ZYME | SELL | 2025-01-06 | $332K | — | Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-11-05 | $135K | — | Filing → |